De hyppigst observerede bivirkninger hos patienter, som fik MabThera var infusionsrelaterede reaktioner, som forekom hos de fleste patienter under første infusion.
The most frequently observed adverse drug reactions (ADRs) in patients receiving MabThera were infusion-related reactions which occurred in the majority of patients during the first infusion.